COVID-19 update included
The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic


Summary

Johnson & Johnson (J&J) provides pharmaceuticals in the immunology, cancer, neuroscience, infectious, cardiovascular and metabolic disease areas through its subsidiary ’Janssen Pharmaceutica’.


Scope

The report provides information and insights into Johnson & Johnson’s including -

  • Insights of its digital transformation strategies
  • Details of various partnerships, network map, in-house launches, and other industry innovation programs
  • Detailed overview of Johnson & Johnson’s technology centers and innovation programs and financial highlights.




Reasons To Buy

  • Gain insights into Johnson & Johnson’s technology innovations.
  • Gain insights into its Digital Transformation Strategy.
  • Gain insights into various product launches, partnership strategies of Johnson & Johnson.
  • Gain insights into various disruptive technologies and tech initiatives of the Company.